scholarly journals Respiratory support with venovenous extracorporeal membrane oxygenation during stent placement for the palliation of critical airway obstruction: case series analysis

2017 ◽  
Vol 9 (8) ◽  
pp. 2599-2607 ◽  
Author(s):  
Jung-Hoon Park ◽  
Ji Hoon Shin ◽  
Kun Yung Kim ◽  
Ju Yong Lim ◽  
Pyeong Hwa Kim ◽  
...  
2020 ◽  
Vol 35 (3) ◽  
pp. 514-521
Author(s):  
Stacy L. Pelekhaty ◽  
Mehrnaz Pajoumand ◽  
Kristen S. Omanwa ◽  
Samuel M. Galvagno Jr ◽  
James H. Lantry ◽  
...  

2012 ◽  
Vol 94 (5) ◽  
pp. 1736-1737 ◽  
Author(s):  
Timothy J. George ◽  
Karly P. Knudsen ◽  
Neel R. Sodha ◽  
Claude A. Beaty ◽  
David Feller-Kopman ◽  
...  

2020 ◽  
pp. 014556132094335
Author(s):  
Zhongyan Chen ◽  
Yong Lv ◽  
Yun Feng

Acute airway obstruction caused by invasive laryngeal cancer can make surgeons reluctant to perform a high-risk tracheostomy, which is life-saving for such patients. In the setting of the current COVID19 pandemic, we present a case of severe transglottic stenosis due to stage IV laryngeal carcinoma, in which gaseous exchange was facilitated by venovenous (VV) extracorporeal membrane oxygenation prior to emergent tracheostomy. The VV technique can ensure adequate oxygenation and CO2 removal. Venovenous extracorporeal membrane oxygenation provided sufficient time for surgical planning and preparation. It reduced the formation of aerosol, lowered the risk associated with life-saving tracheostomy, and protected the patient from ischemia.


2020 ◽  
Vol 7 ◽  
Author(s):  
Mathieu Jozwiak ◽  
Jean-Daniel Chiche ◽  
Julien Charpentier ◽  
Zakaria Ait Hamou ◽  
Paul Jaubert ◽  
...  

Acute respiratory distress syndrome (ARDS) related to Coronavirus disease (COVID-19) is associated with high mortality. It has been suggested that venovenous extracorporeal membrane oxygenation (ECMO) was suitable in this indication, albeit the effects of ECMO on the mechanical respiratory parameters have been scarcely described. In this case-series, we prospectively described the use of venovenous ECMO and its effects on mechanical respiratory parameters in eleven COVID-19 patients with severe ARDS. Implantation of ECMO occurred 6 [3–11] days after the onset of mechanical ventilation. At the time of ECMO implantation, all patients received neuromuscular blocking agents, three (27%) received inhaled nitric oxide and prone positioning was performed in all patients with 4 [3−5] sessions of PP per patient. Under ECMO, the tidal volume was significantly decreased from 6.1 [4.0–6.3] to 3.4 [2.5–3.6] mL/kg of predicted body weight and the positive end-expiratory pressure level was increased by 25 ± 27% whereas the driving pressure and the mechanical power decreased by 33 ± 25% and 71 ± 27%, respectively. The PaO2/FiO2 ratio significantly increased from 68 [58–89] to 168 [137–218] and the oxygenation index significantly decreased from 28 [26–35] to 13 [10–15]. The duration of ECMO was 12 [8–25] days. Nine (82%) patients experienced ECMO-related complications and the main complication was major bleeding requiring blood transfusions. Intensive care unit mortality rate was 55% but no patient died from ECMO-related complications. In COVID-19 patients with severe ARDS, venovenous ECMO allowed ultra-protective ventilation, improved oxygenation and should be considered in highly selected patients with the most severe ARDS.


Sign in / Sign up

Export Citation Format

Share Document